Document is current
Any future updates will be listed below
-
Authors
Frangiamore, Rita https://orcid.org/0000-0002-0383-3791
Rinaldi, Elena https://orcid.org/0000-0003-0744-7238
Vanoli, Fiammetta https://orcid.org/0000-0002-9081-6462
Andreetta, Francesca https://orcid.org/0000-0001-8239-8830
Mantegazza, Renato https://orcid.org/0000-0002-9810-5737
Antozzi, Carlo https://orcid.org/0000-0001-9270-5224
- License Information
-
More Information
Article History
Received: 15 September 2023
Accepted: 3 October 2023
First Online: 24 October 2023
Declarations
:
: R.F. received support for congress participation from Argenx, Biogen, Catalyst, Merck, Momenta, Novartis, and Sanofi Genzyme. F.V. received support for congress participation from Biogen, Kedrion, and Sanofi Genzyme. R.M. received fees and honoraria for meeting, travel, and advisory board from Alexion, Argenx, Biomarin, Catalyst, Merck Serono, UCB.C.A. C.A. received funding for travel, meeting attendance, and advisory board participation from Alexion, Momenta Sanofi, and UCB.
: The Ethics Committee of Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta requires the patients’ consent for case report publication.
